as on November 8, 2025 at 1:39 am IST
Day's Low
Day's High
5.83%
Downside
0.83%
Upside
52 Week's Low
52 Week's High
34.17%
Downside
481.67%
Upside
Check Outlook Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$55.5M
EPS (TTM)
-1.8375
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-3.51
Industry PE ratio
0PEG Ratio
0EBITDA
-72.5M
Revenue (TTM)
1.5M
Profit Margin
0.00%
Return On Equity TTM
-3.65%
Track how Outlook Therapeutics Inc P/E has moved over time to understand its valuation trends.
Outlook Therapeutics Inc in the last 5 years
Lowest (-130.40x)
September 30, 2021
Industry (0.00x)
November 7, 2025
Today (-3.51x)
November 7, 2025
Highest (-0.59x)
June 30, 2025
Today’s Price to Earnings Ratio: -3.51x
Compare market cap, revenue, PE, and other key metrics of Outlook Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $55.5M | -92.8% | -3.51 | 0.00% | |
| BUY | $39.6B | 470.1% | -16.34 | -264.83% | |
| BUY | $57.4B | 236.95% | 1448.53 | 1.36% | |
| BUY | $105.8B | 88.96% | 29.32 | 31.35% | |
| BUY | $67.7B | 11.91% | 15.43 | 32.13% |
The Outlook Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Outlook Therapeutics Inc investment value today
Current value as on today
₹23,098
Returns
Returns from Outlook Therapeutics Inc Stock
Dollar Returns*
₹5,107 (+5.11%)
Based on 13 analysts
92.31%
Buy
7.69%
Hold
0.00%
Sell
Based on 13 analysts, 92.31% of analysts recommend a 'BUY' rating for Outlook Therapeutics Inc. Average target price of $6.25
Get share price movements and forecasts by analysts on Outlook Therapeutics Inc.
What analysts predicted
80.8%UPSIDE
Target Price
$6.25
Current Price
$1.2
Analyzed by
13 Analysts
Target
$6.25
Outlook Therapeutics Inc target price $6.25, a slight upside of 80.8% compared to current price of $1.2. According to 13 analysts rating.
Search interest for Outlook Therapeutics Inc Stock has increased by 32% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:32% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 159.0% return, outperforming this stock by 241.3%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 921.9% return, outperforming this stock by 1016.4%
Price Dip
![]()
In the last 3 months, OTLK stock has moved down by -35.9%
| Organisation | Outlook Therapeutics Inc |
| Headquarters | 111 S. Wood Avenue, Iselin, NJ, United States, 08830 |
| Industry | Health Technology |
| CEO | Mr. Robert Charles Jahr |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Surendra Sharma M.D. | Senior Vice President of Medical Affairs |
Dr. Jennifer M. Kissner Ph.D. | Senior Vice President of Clinical Development & Regulatory Affairs |
Mr. Jedd Comiskey | Senior VP - Head of Europe |
Mr. Lawrence A. Kenyon CPA | EVP, CFO, Treasurer, Secretary & Director |
Mr. Robert Charles Jahr | President, CEO & Director |
Mr. Joel Prieve | Senior Vice President of Licensing and M&A |
Outlook Therapeutics Inc share price today is $1.2 as on . Outlook Therapeutics Inc share today touched a day high of $1.21 and a low of $1.13.
Outlook Therapeutics Inc share touched a 52 week high of $6.98 on and a 52 week low of $0.79 on . Outlook Therapeutics Inc stock price today i.e. is trending at $1.2,which is 82.81% down from its 52 week high and 51.90% up from its 52 week low.
Outlook Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Outlook Therapeutics Inc (OTLK) shares with as little as ₹88.626 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.26 in Outlook Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Outlook Therapeutics Inc share’s latest price of $1.2 as on November 8, 2025 at 1:39 am IST, you will get 8.3333 shares of Outlook Therapeutics Inc. Learn more about
fractional shares .
Outlook Therapeutics Inc stock has given -92.8% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?